483
Colgate-Palmolive CompanyColgate-Palmolive Company – FDA 483, May 30, 2019
Record Details
The FDA inspected Colgate Palmolive Company's Corporate Headquarters in Piscataway, NJ, and issued a Form 483 with one observation. The firm failed to submit copies of product labels with serious adverse event reports for OTC Monograph non-prescription drugs. This indicates a deficiency in their adverse event reporting process.
View Company Profile
ID · 62186d39-57c7-438a-aae3-42bd3b0eda0c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.